Comparing the Cervista HPV HR Test and Hybrid Capture 2 Assay in a Dutch Screening Population: Improved Specificity of the Cervista HPV HR Test by Changing the Cut-Off

作者：Boers Aniek; Slagter Menkema Lorian; van Hemel Bettien M; Belinson Jerome L; Ruitenbeek Teus; Buikema Henk J; Klip Harry; Ghyssaert Hilde; van der Zee Ate G J; de Bock Geertruida H; Wisman G Bea A; Schuuring Ed^*

来源：PLos One, 2014, 9(7): e101930.

DOI：10.1371/journal.pone.0101930

The diagnostic performance of the widely-used Cervista HPV HR test was compared to the Hybrid Capture 2 (HC2) test in a Dutch population-based cervical cancer screening program. In 900 scrapings of women with normal cytomorphology, specificity was 90% (95% CI: 87.84-91.87) for the Cervista HPV HR test and 96% (95% CI: 94.76-97.37) for the HC2 test with 93% agreement between both tests (kappa = 0.5, p<0.001). The sensitivity for CIN2+ using 65 scrapings of women with histological-confirmed CIN2+ was 91% (95% CI: 80.97-96.51) for the Cervista HPV HR test and 92% (95% CI: 82.94-97.43) for the HC2 test with 95% agreement between both tests (kappa = 0.7, p<0.001). Fifty-seven of 60 HC2 negative/Cervista positive cases tested HPV-negative with PCR-based HPV assays; of these cases 56% were defined as Cervista triple-positive with FOZ values in all 3 mixes higher than the second cut-off of 1.93 (as set by manufacturer). By setting this cut-off at 5.0, specificity improved significantly without affecting sensitivity. External validation of this new cut-off at 5.0 in triple-positive scrapings of women selected from the SHENCCASTII database revealed that 22/24 histological normal cases now tested HPV-negative in the Cervista HPV HR test, while CIN2+ lesions remained HPV-positive. The intra-laboratory reproducibility of the Cervista HPV HR test (n = 510) showed a concordance of 92% and 93% for cut-off 1.93 and 5.0 (kappa = 0.83 and kappa = 0.84, p<0.001) and inter-laboratory agreement of the Cervista HPV HR test was 90% and 93% for cut-off 1.93 and 5.0 (kappa = 0.80 and kappa = 0.85, p<0.001). In conclusion, the specificity of the Cervista HPV HR test could be improved significantly by increasing the second cut-off from 1.93 to 5.0, without affecting the sensitivity of the test in a population-based screening setting.

• 出版日期2014-7-22